The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global TIGIT Therapies Market Research Report 2025
Synopsis
The global TIGIT Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for TIGIT Therapies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for TIGIT Therapies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for TIGIT Therapies in Cell Carcinoma is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of TIGIT Therapies include Roche, Merck, AstraZeneca, Arcus, Astellas, BeiGene, BMS, Junshi Biosciences and Innovent Biologics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for TIGIT Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TIGIT Therapies.
Report Scope
The TIGIT Therapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global TIGIT Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the TIGIT Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Merck
AstraZeneca
Arcus
Astellas
BeiGene
BMS
Junshi Biosciences
Innovent Biologics
Mereo BioPharma
Seattle Genetics
Hengrui Medicine
Compugen
Segment by Type
Monotherapy
Combination Therapy
Segment by Application
Cell Carcinoma
Solid Tumor
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of TIGIT Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global TIGIT Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for TIGIT Therapies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for TIGIT Therapies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for TIGIT Therapies in Cell Carcinoma is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of TIGIT Therapies include Roche, Merck, AstraZeneca, Arcus, Astellas, BeiGene, BMS, Junshi Biosciences and Innovent Biologics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for TIGIT Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TIGIT Therapies.
Report Scope
The TIGIT Therapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global TIGIT Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the TIGIT Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Merck
AstraZeneca
Arcus
Astellas
BeiGene
BMS
Junshi Biosciences
Innovent Biologics
Mereo BioPharma
Seattle Genetics
Hengrui Medicine
Compugen
Segment by Type
Monotherapy
Combination Therapy
Segment by Application
Cell Carcinoma
Solid Tumor
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of TIGIT Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global TIGIT Therapies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global TIGIT Therapies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cell Carcinoma
1.3.3 Solid Tumor
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global TIGIT Therapies Market Perspective (2019-2030)
2.2 TIGIT Therapies Growth Trends by Region
2.2.1 Global TIGIT Therapies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 TIGIT Therapies Historic Market Size by Region (2019-2024)
2.2.3 TIGIT Therapies Forecasted Market Size by Region (2025-2030)
2.3 TIGIT Therapies Market Dynamics
2.3.1 TIGIT Therapies Industry Trends
2.3.2 TIGIT Therapies Market Drivers
2.3.3 TIGIT Therapies Market Challenges
2.3.4 TIGIT Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top TIGIT Therapies Players by Revenue
3.1.1 Global Top TIGIT Therapies Players by Revenue (2019-2024)
3.1.2 Global TIGIT Therapies Revenue Market Share by Players (2019-2024)
3.2 Global TIGIT Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by TIGIT Therapies Revenue
3.4 Global TIGIT Therapies Market Concentration Ratio
3.4.1 Global TIGIT Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by TIGIT Therapies Revenue in 2023
3.5 TIGIT Therapies Key Players Head office and Area Served
3.6 Key Players TIGIT Therapies Product Solution and Service
3.7 Date of Enter into TIGIT Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 TIGIT Therapies Breakdown Data by Type
4.1 Global TIGIT Therapies Historic Market Size by Type (2019-2024)
4.2 Global TIGIT Therapies Forecasted Market Size by Type (2025-2030)
5 TIGIT Therapies Breakdown Data by Application
5.1 Global TIGIT Therapies Historic Market Size by Application (2019-2024)
5.2 Global TIGIT Therapies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America TIGIT Therapies Market Size (2019-2030)
6.2 North America TIGIT Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America TIGIT Therapies Market Size by Country (2019-2024)
6.4 North America TIGIT Therapies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe TIGIT Therapies Market Size (2019-2030)
7.2 Europe TIGIT Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe TIGIT Therapies Market Size by Country (2019-2024)
7.4 Europe TIGIT Therapies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific TIGIT Therapies Market Size (2019-2030)
8.2 Asia-Pacific TIGIT Therapies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific TIGIT Therapies Market Size by Region (2019-2024)
8.4 Asia-Pacific TIGIT Therapies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America TIGIT Therapies Market Size (2019-2030)
9.2 Latin America TIGIT Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America TIGIT Therapies Market Size by Country (2019-2024)
9.4 Latin America TIGIT Therapies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa TIGIT Therapies Market Size (2019-2030)
10.2 Middle East & Africa TIGIT Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa TIGIT Therapies Market Size by Country (2019-2024)
10.4 Middle East & Africa TIGIT Therapies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche TIGIT Therapies Introduction
11.1.4 Roche Revenue in TIGIT Therapies Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck TIGIT Therapies Introduction
11.2.4 Merck Revenue in TIGIT Therapies Business (2019-2024)
11.2.5 Merck Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca TIGIT Therapies Introduction
11.3.4 AstraZeneca Revenue in TIGIT Therapies Business (2019-2024)
11.3.5 AstraZeneca Recent Development
11.4 Arcus
11.4.1 Arcus Company Detail
11.4.2 Arcus Business Overview
11.4.3 Arcus TIGIT Therapies Introduction
11.4.4 Arcus Revenue in TIGIT Therapies Business (2019-2024)
11.4.5 Arcus Recent Development
11.5 Astellas
11.5.1 Astellas Company Detail
11.5.2 Astellas Business Overview
11.5.3 Astellas TIGIT Therapies Introduction
11.5.4 Astellas Revenue in TIGIT Therapies Business (2019-2024)
11.5.5 Astellas Recent Development
11.6 BeiGene
11.6.1 BeiGene Company Detail
11.6.2 BeiGene Business Overview
11.6.3 BeiGene TIGIT Therapies Introduction
11.6.4 BeiGene Revenue in TIGIT Therapies Business (2019-2024)
11.6.5 BeiGene Recent Development
11.7 BMS
11.7.1 BMS Company Detail
11.7.2 BMS Business Overview
11.7.3 BMS TIGIT Therapies Introduction
11.7.4 BMS Revenue in TIGIT Therapies Business (2019-2024)
11.7.5 BMS Recent Development
11.8 Junshi Biosciences
11.8.1 Junshi Biosciences Company Detail
11.8.2 Junshi Biosciences Business Overview
11.8.3 Junshi Biosciences TIGIT Therapies Introduction
11.8.4 Junshi Biosciences Revenue in TIGIT Therapies Business (2019-2024)
11.8.5 Junshi Biosciences Recent Development
11.9 Innovent Biologics
11.9.1 Innovent Biologics Company Detail
11.9.2 Innovent Biologics Business Overview
11.9.3 Innovent Biologics TIGIT Therapies Introduction
11.9.4 Innovent Biologics Revenue in TIGIT Therapies Business (2019-2024)
11.9.5 Innovent Biologics Recent Development
11.10 Mereo BioPharma
11.10.1 Mereo BioPharma Company Detail
11.10.2 Mereo BioPharma Business Overview
11.10.3 Mereo BioPharma TIGIT Therapies Introduction
11.10.4 Mereo BioPharma Revenue in TIGIT Therapies Business (2019-2024)
11.10.5 Mereo BioPharma Recent Development
11.11 Seattle Genetics
11.11.1 Seattle Genetics Company Detail
11.11.2 Seattle Genetics Business Overview
11.11.3 Seattle Genetics TIGIT Therapies Introduction
11.11.4 Seattle Genetics Revenue in TIGIT Therapies Business (2019-2024)
11.11.5 Seattle Genetics Recent Development
11.12 Hengrui Medicine
11.12.1 Hengrui Medicine Company Detail
11.12.2 Hengrui Medicine Business Overview
11.12.3 Hengrui Medicine TIGIT Therapies Introduction
11.12.4 Hengrui Medicine Revenue in TIGIT Therapies Business (2019-2024)
11.12.5 Hengrui Medicine Recent Development
11.13 Compugen
11.13.1 Compugen Company Detail
11.13.2 Compugen Business Overview
11.13.3 Compugen TIGIT Therapies Introduction
11.13.4 Compugen Revenue in TIGIT Therapies Business (2019-2024)
11.13.5 Compugen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global TIGIT Therapies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global TIGIT Therapies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global TIGIT Therapies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global TIGIT Therapies Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global TIGIT Therapies Market Share by Region (2019-2024)
Table 8. Global TIGIT Therapies Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global TIGIT Therapies Market Share by Region (2025-2030)
Table 10. TIGIT Therapies Market Trends
Table 11. TIGIT Therapies Market Drivers
Table 12. TIGIT Therapies Market Challenges
Table 13. TIGIT Therapies Market Restraints
Table 14. Global TIGIT Therapies Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global TIGIT Therapies Market Share by Players (2019-2024)
Table 16. Global Top TIGIT Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TIGIT Therapies as of 2023)
Table 17. Ranking of Global Top TIGIT Therapies Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by TIGIT Therapies Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players TIGIT Therapies Product Solution and Service
Table 21. Date of Enter into TIGIT Therapies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global TIGIT Therapies Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global TIGIT Therapies Revenue Market Share by Type (2019-2024)
Table 25. Global TIGIT Therapies Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global TIGIT Therapies Revenue Market Share by Type (2025-2030)
Table 27. Global TIGIT Therapies Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global TIGIT Therapies Revenue Market Share by Application (2019-2024)
Table 29. Global TIGIT Therapies Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global TIGIT Therapies Revenue Market Share by Application (2025-2030)
Table 31. North America TIGIT Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America TIGIT Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America TIGIT Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe TIGIT Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe TIGIT Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe TIGIT Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific TIGIT Therapies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific TIGIT Therapies Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific TIGIT Therapies Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America TIGIT Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America TIGIT Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America TIGIT Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa TIGIT Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa TIGIT Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa TIGIT Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 46. Roche Company Detail
Table 47. Roche Business Overview
Table 48. Roche TIGIT Therapies Product
Table 49. Roche Revenue in TIGIT Therapies Business (2019-2024) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Merck Company Detail
Table 52. Merck Business Overview
Table 53. Merck TIGIT Therapies Product
Table 54. Merck Revenue in TIGIT Therapies Business (2019-2024) & (US$ Million)
Table 55. Merck Recent Development
Table 56. AstraZeneca Company Detail
Table 57. AstraZeneca Business Overview
Table 58. AstraZeneca TIGIT Therapies Product
Table 59. AstraZeneca Revenue in TIGIT Therapies Business (2019-2024) & (US$ Million)
Table 60. AstraZeneca Recent Development
Table 61. Arcus Company Detail
Table 62. Arcus Business Overview
Table 63. Arcus TIGIT Therapies Product
Table 64. Arcus Revenue in TIGIT Therapies Business (2019-2024) & (US$ Million)
Table 65. Arcus Recent Development
Table 66. Astellas Company Detail
Table 67. Astellas Business Overview
Table 68. Astellas TIGIT Therapies Product
Table 69. Astellas Revenue in TIGIT Therapies Business (2019-2024) & (US$ Million)
Table 70. Astellas Recent Development
Table 71. BeiGene Company Detail
Table 72. BeiGene Business Overview
Table 73. BeiGene TIGIT Therapies Product
Table 74. BeiGene Revenue in TIGIT Therapies Business (2019-2024) & (US$ Million)
Table 75. BeiGene Recent Development
Table 76. BMS Company Detail
Table 77. BMS Business Overview
Table 78. BMS TIGIT Therapies Product
Table 79. BMS Revenue in TIGIT Therapies Business (2019-2024) & (US$ Million)
Table 80. BMS Recent Development
Table 81. Junshi Biosciences Company Detail
Table 82. Junshi Biosciences Business Overview
Table 83. Junshi Biosciences TIGIT Therapies Product
Table 84. Junshi Biosciences Revenue in TIGIT Therapies Business (2019-2024) & (US$ Million)
Table 85. Junshi Biosciences Recent Development
Table 86. Innovent Biologics Company Detail
Table 87. Innovent Biologics Business Overview
Table 88. Innovent Biologics TIGIT Therapies Product
Table 89. Innovent Biologics Revenue in TIGIT Therapies Business (2019-2024) & (US$ Million)
Table 90. Innovent Biologics Recent Development
Table 91. Mereo BioPharma Company Detail
Table 92. Mereo BioPharma Business Overview
Table 93. Mereo BioPharma TIGIT Therapies Product
Table 94. Mereo BioPharma Revenue in TIGIT Therapies Business (2019-2024) & (US$ Million)
Table 95. Mereo BioPharma Recent Development
Table 96. Seattle Genetics Company Detail
Table 97. Seattle Genetics Business Overview
Table 98. Seattle Genetics TIGIT Therapies Product
Table 99. Seattle Genetics Revenue in TIGIT Therapies Business (2019-2024) & (US$ Million)
Table 100. Seattle Genetics Recent Development
Table 101. Hengrui Medicine Company Detail
Table 102. Hengrui Medicine Business Overview
Table 103. Hengrui Medicine TIGIT Therapies Product
Table 104. Hengrui Medicine Revenue in TIGIT Therapies Business (2019-2024) & (US$ Million)
Table 105. Hengrui Medicine Recent Development
Table 106. Compugen Company Detail
Table 107. Compugen Business Overview
Table 108. Compugen TIGIT Therapies Product
Table 109. Compugen Revenue in TIGIT Therapies Business (2019-2024) & (US$ Million)
Table 110. Compugen Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global TIGIT Therapies Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global TIGIT Therapies Market Share by Type: 2023 VS 2030
Figure 3. Monotherapy Features
Figure 4. Combination Therapy Features
Figure 5. Global TIGIT Therapies Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global TIGIT Therapies Market Share by Application: 2023 VS 2030
Figure 7. Cell Carcinoma Case Studies
Figure 8. Solid Tumor Case Studies
Figure 9. TIGIT Therapies Report Years Considered
Figure 10. Global TIGIT Therapies Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global TIGIT Therapies Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global TIGIT Therapies Market Share by Region: 2023 VS 2030
Figure 13. Global TIGIT Therapies Market Share by Players in 2023
Figure 14. Global Top TIGIT Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TIGIT Therapies as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by TIGIT Therapies Revenue in 2023
Figure 16. North America TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America TIGIT Therapies Market Share by Country (2019-2030)
Figure 18. United States TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe TIGIT Therapies Market Share by Country (2019-2030)
Figure 22. Germany TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific TIGIT Therapies Market Share by Region (2019-2030)
Figure 30. China TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America TIGIT Therapies Market Share by Country (2019-2030)
Figure 38. Mexico TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa TIGIT Therapies Market Share by Country (2019-2030)
Figure 42. Turkey TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia TIGIT Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Roche Revenue Growth Rate in TIGIT Therapies Business (2019-2024)
Figure 45. Merck Revenue Growth Rate in TIGIT Therapies Business (2019-2024)
Figure 46. AstraZeneca Revenue Growth Rate in TIGIT Therapies Business (2019-2024)
Figure 47. Arcus Revenue Growth Rate in TIGIT Therapies Business (2019-2024)
Figure 48. Astellas Revenue Growth Rate in TIGIT Therapies Business (2019-2024)
Figure 49. BeiGene Revenue Growth Rate in TIGIT Therapies Business (2019-2024)
Figure 50. BMS Revenue Growth Rate in TIGIT Therapies Business (2019-2024)
Figure 51. Junshi Biosciences Revenue Growth Rate in TIGIT Therapies Business (2019-2024)
Figure 52. Innovent Biologics Revenue Growth Rate in TIGIT Therapies Business (2019-2024)
Figure 53. Mereo BioPharma Revenue Growth Rate in TIGIT Therapies Business (2019-2024)
Figure 54. Seattle Genetics Revenue Growth Rate in TIGIT Therapies Business (2019-2024)
Figure 55. Hengrui Medicine Revenue Growth Rate in TIGIT Therapies Business (2019-2024)
Figure 56. Compugen Revenue Growth Rate in TIGIT Therapies Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
